[Drug-Induced Akathisia]

Brain Nerve. 2017 Dec;69(12):1417-1424. doi: 10.11477/mf.1416200927.
[Article in Japanese]

Abstract

Akathisia consists of subjective inner restlessness, such as awareness of the inability to remain seated, restless legs, fidgetiness, and the desire to move constantly, and of objective increased motor phenomena, such as body rocking, shifting from foot to foot, stamping in place, crossing and uncrossing legs, pacing around. Although the broad definition of akathisia includes the inner and motor restlessness observed in patients with idiopathic Parkinson's disease, post-encephalitic parkinsonism, and restless legs syndrome, here we exclusively focus on the narrow definition of antipsychotic-induced akathisia. The most reliable treatment for acute akathisia is the reduction or the withdrawal of antipsychotic medication. However, this is often not possible because it may worsen the patients' mental condition. Various pharmacological agents have been used for the treatment of this condition. These include anticholinergic agents (e.g., biperiden and trihexyphenidyl), benzodiazepines, beta-adrenoceptor blockers (e.g., propranolol), and serotonin 2A receptor antagonists (e.g., mianserin, cyproheptadine, and mirtazapine).

MeSH terms

  • Akathisia, Drug-Induced* / drug therapy
  • Akathisia, Drug-Induced* / epidemiology
  • Akathisia, Drug-Induced* / physiopathology
  • Antipsychotic Agents / adverse effects
  • Disease Progression
  • Humans
  • Practice Guidelines as Topic
  • Restless Legs Syndrome
  • Severity of Illness Index

Substances

  • Antipsychotic Agents